Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kavi Devulapalli

Vascular & Interventional Radiology Columbia, MO Medical Doctor

NPI 1881950749 CMS profile 2788222

1 S Keene St, Columbia, MO 65201

Open in the dashboard

General payments

$78,019

327 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kavi Devulapalli of Columbia, MO is reported in the CMS Open Payments database as having received $78,019 across 327 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $32,222 82
2024 General $36,225 76
2023 General $3,574 36
2022 General $984 13
2021 General $740 32
2020 General $1,782 52
2019 General $2,491 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kavi Devulapalli
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Kavi Devulapalli were reported at $32,222. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Kavi Devulapalli Vascular & Interventional Radiology median Middle half National median
2019 $2,491 $422 $125–$1,555 $163
2020 $1,782 $200 $68–$652 $114
2021 $740 $280 $99–$866 $132
2022 $984 $433 $137–$1,497 $149
2023 $3,574 $506 $152–$2,019 $160
2024 $36,225 $556 $175–$1,930 $164
2025 $32,222 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Terumo Medical Corporation $51,023 90 payments
  2. Asahi Intecc USA, Inc. $9,540 11 payments
  3. Inari Medical, Inc. $3,431 35 payments
  4. Cook Incorporated $2,948 4 payments
  5. Nevro Corp. $1,959 8 payments
  6. Medtronic, Inc. $1,813 26 payments
  7. Cardiovascular Systems Inc. $1,683 31 payments
  8. Abbott Laboratories $1,484 29 payments
  9. Cook Medical LLC $752 7 payments
  10. Medtronic USA, Inc. $628 18 payments
  11. Other $2,758 68 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $43,810 25 payments
  2. Food and Beverage $11,113 251 payments
  3. Travel and Lodging $10,646 47 payments
  4. Honoraria $10,000 3 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,450 1 payment
Products named General payments · program years 2019–2025
  1. GLIDESHEATH SLENDER $17,374 39 payments
  2. PROGREAT $15,806 10 payments
  3. Azur CX Detachable $8,832 12 payments
  4. TR BAND $8,516 6 payments
  5. PERIPHERAL VASCULAR $8,332 7 payments
  6. FLOWTRIEVER CATHETER, S $3,534 37 payments
  7. CT THROMBECTOMY SYSTEM KIT $3,327 33 payments
  8. Cook $2,450 1 payment
  9. Senza $1,178 3 payments
  10. KYPHON EXPRESS II KYPHOPAK TRAY $1,052 8 payments
  11. Other $11,140 208 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 161 billing codes

Paid by Medicare

$65,612

Medicare's payments for the services billed

Medicare patients

1,136

Average age 75

Services billed

1,817

624 women, 512 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Ischemic heart disease 49%
Diabetes 45%
Chronic kidney disease 42%
Heart failure 39%
Depression 38%
COPD 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

327 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record